Cirrhosis is one of the leading causes of mortality from non-communicable diseases, with complications arising as liver ...

Extrafine single inhaler triple therapy is effective among patients with COPD who were previously treated with multiple-inhaler triple therapy.

Toby Maher, MD, PhD, professor of clinical medicine, Keck Medicine of USC, discusses the impact of changes in lung function in patients with idiopathic pulmonary fibrosis (IPF).

Lung disease affects around 1 in 7 older persons, making it a serious health risk. Among persons 60 years of age and older, ...

RESPICON 2024 organised between 27th and 29th September witnessed a significant milestone in the field of pulmonary medicine ...

Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.

Caroline Quill, MD, of the University of Rochester Medical Center, highlighted the potential of artificial intelligence (AI) ...

Nerandomilast demonstrated it was able to outperform a placebo at improving lung function in IPF or preventing its decline ...

"If we had an easy-to-implement clinical tool, like a blood test, that captured someone's lung function ... the long run, improve lung health," Kalhan added. Chronic obstructive pulmonary disease ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing ...

Respiratory medicine is one frontier of the global healthcare landscape which has undergone significant transformations in ...